LDL Receptor Polyclonal Antibody

LDL Receptor Polyclonal Antibody Struktur
CAS-Nr.
Englisch Name:
LDL Receptor Polyclonal Antibody
Synonyma:
LDL Receptor Polyclonal Antibody
CBNumber:
CB32591570
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

LDL Receptor Polyclonal Antibody Eigenschaften

Sicherheit

LDL Receptor Polyclonal Antibody Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Cholesterol is an essential element of cell membranes and is carried around the body packaged in lipoproteins, primarily low-density lipoproteins (LDLs). The LDL receptors (LDLRs) are cell surface glycoproteins that scavenge LDL from the blood and regulate plasma LDL cholesterol. LDLRs contain five primary domains: the ligand binding domain, the homology with the EGF precursor domain, the O-linked sugars domain, the membrane-spanning region, and a cytoplasmic tail. In humans, more than 60% of the LDL R3 are found in the liver. LDLR expression is under hormonal control both in vivo and in vitro. Mutations in the LDLR gene cause disorders such as familial hypercholesterolemia and atherosclerosis. Murine LDLR is 864 amino acids in length with an estimated molecular weight of 95 kDa. The protein is highly glycosylated through N- and O-linkages and thus migrates at 100 to 160 kDa bands on SDS-PAGE. Cayman’s LDL receptor polyclonal antibody detects both glycosylated and unglycosylated proteins in tissue/cell samples such as liver, HepG2, and RAW 264.7 cells.

LDL Receptor Polyclonal Antibody Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


LDL Receptor Polyclonal Antibody Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Cayman Chemical Company --
cayman@caymanchem.com United States 6618 81

  • LDL Receptor Polyclonal Antibody
Copyright 2019 © ChemicalBook. All rights reserved